Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Silvia Affò, Ajay Nair, Francesco Brundu, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 866-882.e11
Open Access | Times Cited: 267

Showing 26-50 of 267 citing articles:

Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Bruno Cogliati, Chittampalli Yashaswini, Shuang Wang, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 647-661
Open Access | Times Cited: 53
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 50
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
Ying Fan, Mandy Sze Man Chan, Terence K. Lee
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 4, pp. 985-999
Open Access | Times Cited: 48
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 48
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 26
Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis‐Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment
Yuan Zhi, Qian Wang, Moxin Zi, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 20
Single cell deciphering of progression trajectories of the tumor ecosystem in head and neck cancer
Zhanli Liu, Xiangyan Meng, Rujuan Bao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 20
TSPAN8 + myofibroblastic cancer–associated fibroblasts promote chemoresistance in patients with breast cancer
Guangjian Fan, Bo Yu, Lei Tang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 741
Open Access | Times Cited: 20
WNT-dependent interaction between inflammatory fibroblasts and FOLR2+ macrophages promotes fibrosis in chronic kidney disease
Camille Cohen, Rana Mhaidly, Hugo Croizer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 16
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 4
Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4+ and CD8+ T cells
Feilong Ren, Lin Meng, Shize Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 2
Single-cell Transcriptomics Reveals Intratumor Heterogeneity and the Potential Roles of Cancer Stem Cells and myCAFs in Colorectal Cancer Liver Metastasis and Recurrence
Zhan Yao, Dong Sun, Jie Gao, et al.
Cancer Letters (2025), pp. 217452-217452
Closed Access | Times Cited: 1
Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging
Agathe Peltier, Romain-David Seban, Irène Buvat, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 262-272
Open Access | Times Cited: 62
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment
Yifei Zhu, Xinyan Li, Lei Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 61
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets
Shinelle Menezes, Mohamed Hazem Okail, Siti Munira Abd Jalil, et al.
The Journal of Pathology (2022) Vol. 257, Iss. 4, pp. 526-544
Open Access | Times Cited: 51
Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2350-2371
Open Access | Times Cited: 50
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
Jian Lin, Yuting Dai, Chen Sang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004892-e004892
Open Access | Times Cited: 46
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype
Wenfeng Zeng, Lixiong Xiong, Wei Wu, et al.
Oncogene (2022) Vol. 42, Iss. 3, pp. 224-237
Open Access | Times Cited: 43
Advances of cancer-associated fibroblasts in liver cancer
Hao Peng, Erwei Zhu, Yewei Zhang
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer
Zhonglin Zhu, Qiuyan Zhao, Song Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
Shenglong Li, Yue Kang, Yu Zeng
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189033-189033
Closed Access | Times Cited: 39
Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study
Shaoquan Zheng, Jie‐Ying Liang, Yuhui Tang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 34

Scroll to top